Diarrhea Current Events | Diarrhea News | 4
|
|
|
Sort By:
Page Views | Date |
Appendix isn't useless at all: It's a safe house for bacteria
Long denigrated as vestigial or useless, the appendix now appears to have a reason to be - as a "safe house" for the beneficial bacteria living in the human gut. view more (2007-10-09)
How to diagnose and treat Gardner syndrome with gastric polyposis
Gardner syndrome (GS) is a rare, autosomal, dominant inherited disorder with a high degree of penetrance characterized by the triad: intestinal polyposis and various bone and soft-tissue tumors. It is regarded as a clinical subgroup of familial adenomatous polyposis (FAP). view more (2008-05-21)
New studies gauge knowledge, attitudes and preferences of patients with irritable bowel syndrome
Significant misconceptions about the causes of their condition and mistaken beliefs about its potential progression into other diseases, including cancer, marks the knowledge of a sample of patients with Irritable Bowel Syndrome (IBS). view more (2005-10-31)
Eating right, not supplements, is best at keeping your good bacteria healthy, dietitian says
Healthy eating, not supplements, is the best way to keep the good bacteria in your gut healthy, says a dietitian and researcher. view more (2009-10-22)
A new alternative in treating short bowel syndrome
SBS is a clinical condition characterized by diarrhea, dehydration, electrolyte imbalance, malabsorption, and progressive malnutrition related to a wide resection of the small intestine. view more (2008-10-13)
ZOLINZA (vorinostat) in combination with bortezomib demonstrated clinical activity
Results from two investigational Phase I trials of ZOLINZA® (vorinostat) in combination with bortezomib provide preliminary anti-tumor activity in patients with relapsed and/or refractory multiple myeloma. view more (2007-12-10)
Gene mutation increases drug toxicity, rejection risk in pediatric kidney transplants
Screening for mutations in a gene that helps the body metabolize a kidney transplant anti-rejection drug may predict which children are at higher risk for side effects, including compromised white blood cell count or organ rejection, according to new research. view more (2009-02-18)
Asthma a significant risk factor for complications in children with H1N1
A new study on pediatric H1N1 influenza admissions has found that asthma is a significant risk factor for severe disease in children with pandemic H1N1 compared with the seasonal flu. view more (2009-11-20)
Antibiotics take toll on beneficial microbes in gut
It's common knowledge that a protective navy of bacteria normally floats in our intestinal tracts. Antibiotics at least temporarily disturb the normal balance. view more (2009-06-19)
The bowels of infection
Current research suggests that latent cytomegalovirus (CMV) infection may exacerbate inflammatory bowel disease (IBD). The related report by Onyeagocha et al, "Latent cytomegalovirus infection exacerbates experimental colitis," appears in the November 2009 issue of The American Journal of Pathology. view more (2009-10-21)
Consumption of raw fish raises potential health concerns for consumers
Two case studies from Japan presented at the 72nd Annual Meeting of the American College of Gastroenterology point to a potential health problem in the United States, as more Americans consume raw fish in the form of sushi and sashimi. Anisakiasis (round worm) is a human parasitic infection caused by the consumption of raw or undercooked seafood... view more... (2007-10-15)
Got zinc? New zinc research suggests novel therapeutic targets
Everyone knows that vitamins "from A to zinc" are important for good health. Now, a new research study in the August 2009 print issue of the Journal of Leukocyte Biology suggests that zinc may be pointing the way to new therapeutic targets for fighting infections. view more (2009-07-31)
APIC launches first national C. difficile prevalence study
The Association for Professionals in Infection Control and Epidemiology (APIC) today announced a detailed strategy to combat Clostridium difficile-associated disease (CDAD). view more (2008-03-24)
Studies assess effectiveness of serotonin and nerve stimulants on irritable bowel syndromes
Studies have shown that gastrointestinal (GI) tract function is often influenced by specific stimulants or reactors, which sometimes cause irritable bowel syndrome (IBS) or constipation. view more (2007-05-22)
The biggest bug in gut discomfort
In spite of our long and painful relationship with Campylobacter jejuni, we are just starting to answer basic questions about the bug that is the leading cause of bacterial food-borne illness in the United States, and one of the most common causes of diarrhea worldwide. view more (2006-12-13)
The balance shifts
The risk of contracting a Clostridium difficile infection following operations for which a "prophylactic" antibiotic is given to prevent infection is 21 times greater now than it was just a decade ago, according to researchers from the University of Sherbrooke in Canada. They report their findings in the June 15 issue of Clinical... view more... (2008-05-28)
Fox Chase finds all-biologic regimen efficacious and well-tolerated in elderly lung cancer patients
Previously untreated non-small cell lung cancer (NSCLC) patients over the age of 70 respond well to a combination of bevacizumab and erlotinib, Fox Chase Cancer Center researchers reported today at the annual meeting of the International Association for the Study of Lung Cancer. view more (2009-08-03)
CCFA survey finds the majority of ulcerative colitis patients are not compliant with medications
A new, large survey supported by the Crohn's & Colitis Foundation of America (CCFA) finds that 65 percent of ulcerative colitis (UC) patients are less than fully compliant with first-line therapies to treat their disease. view more (2006-12-20)
Prescription painkillers effective in patients with dormant inflammatory bowel disease
According to two studies published today in the American Gastroenterological Association (AGA) journal Clinical Gastroenterology and Hepatology, prescription painkillers are effective in easing the pain of patients with dormant inflammatory bowel disease (IBD) and are not likely to cause symptom flare-ups in IBD patients in remissions. view more (2006-02-03)
New study finds advanced liver cancer patients live longer by taking anti-cancer drug sorafenib
Researchers at Mount Sinai School of Medicine in New York have found that sorafenib (Nexavar) helps patients with advanced liver cancer live about 44 percent longer compared with patients who did not receive the anti-cancer drug. view more (2008-07-24)
|
|
|
|
Sort By:
Page Views | Date |
|
